 |
Sunday, May 4, 2014
Ramada Plaza
160 Frontage Road, Newark NJ 07114
The Northeast BONENT Regional Education Seminar was held on Sunday, May 4th in Newark, NJ. It started with a presentation on the “Politics of Dialysis” by Dr. Tom McCune, which was an interesting look at large dialysis organization (LDO) versus small dialysis organizations (SDO). Because of the interest, we are going to try to continue to have speakers on the future of dialysis.
There were presentations on what is new in the dialysis world, access, nocturnal in-center HD, and more. See more details in the presentations section below.
President’s Award Presented
John Larsen, CHT of Terre Haute IN was given the President’s Award by BONENT President RJ Picciano (photo top left), for his tireless efforts working on the Continuing Education Programs Committee over the past year.
Click photos to see slide show.
Presentations Overview
Politics in the Dialysis Unit
We discussed how ethnicity, gender, and socioeconomic status affect patient care and how the type of vascular access obtained and referral to a transplant center is affected by ethnicity.
Thomas McCune, R Col., US Army
Forging Ahead
Attendees participated in a discussion of the current CMS ESRD Contract, USRDS and NHSN data characterizing the NW3 area and some of the NW3 quality improvement projects implemented by the Network to address areas in need of improvement. You will also participate in a questionnaire about QIP.
Karen Ripkey, RN, CNN
Quality Improvement Coordinator
Quality Insights Renal Network 3
Benefits of In-Center Nocturnal Hemodialysis
The presentation explored the benefits of in center nocturnal hemodialysis both for the patient and the host clinic. 8 cases were discussed. Included were pre nocturnal and post nocturnal lab results, clinical outcomes, and noted changes by the patients themselves.
Diana Shelkov, CHT
A Unique Vascular Access Solution to Decrease Catheters and Rescue Failing Fistulas and Grafts
The HeRO Graft is indicated for use for patients who have central venous stenosis. It is FDA approved as a graft.
Todd Trego
HHD from the Patient Perspective
Attendees heard the patient side of dialysis, his choices and benefits of doing home therapy.
David Rush
Kidney Transplant Recipient
The Use of Allografts for Hemodialysis Access
Attendees learned about the use of cryopreserved human tissue to preserve AVG sites.
Todd Trego
Introduction to Home Dialysis With the Patient Experience
Those present learned clinical information regarding the therapy and equipment of home dialysis.
Kim Davis
NxStage